• English
  • Sign In
  • Contact Us
×
Catalog Products » Other Products » Catalog Peptides » All Catalog Peptides » LCMV gp33–41

LCMV gp33–41

Description This is the H-2Db restricted epitope derived from the lymphocytic choreomeningitis virus (LCMV) glycoprotein gp 33; residues 33 to 41.
Sequence
{Lys}{Ala}{Val}{Tyr}{Asn}{Phe}{Ala}{Thr}{Met}
Sequence Shortening KAVYNFATM
Molecular Formula C48H73N11O13S
Molecular Weight 1044.25

Gmp Flag 0
Note


Spiotto, M. and H. Schreiber Cancer Immunity 5, 8 (2005).

Gujar SA., et al. Oncolytic virus-initiated protective immunity against prostate cancer. Mol Ther. 2011 Apr;19(4):797-804.

Gujar S., et al. Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation. Mol Ther. 2013 Feb;21(2):338-47.

You can visit "Citations Database" for more citations.







For more documents, please visit "Technical Support".

Cat. No. RP20257
Size
Price
1 mg $56.00